Correlation Between SYN Tech and Medigen Vaccine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SYN Tech and Medigen Vaccine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SYN Tech and Medigen Vaccine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SYN Tech Chem Pharm and Medigen Vaccine Biologics, you can compare the effects of market volatilities on SYN Tech and Medigen Vaccine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SYN Tech with a short position of Medigen Vaccine. Check out your portfolio center. Please also check ongoing floating volatility patterns of SYN Tech and Medigen Vaccine.

Diversification Opportunities for SYN Tech and Medigen Vaccine

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between SYN and Medigen is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding SYN Tech Chem Pharm and Medigen Vaccine Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigen Vaccine Biologics and SYN Tech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SYN Tech Chem Pharm are associated (or correlated) with Medigen Vaccine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigen Vaccine Biologics has no effect on the direction of SYN Tech i.e., SYN Tech and Medigen Vaccine go up and down completely randomly.

Pair Corralation between SYN Tech and Medigen Vaccine

Assuming the 90 days trading horizon SYN Tech Chem Pharm is expected to generate 0.67 times more return on investment than Medigen Vaccine. However, SYN Tech Chem Pharm is 1.5 times less risky than Medigen Vaccine. It trades about 0.21 of its potential returns per unit of risk. Medigen Vaccine Biologics is currently generating about -0.19 per unit of risk. If you would invest  9,320  in SYN Tech Chem Pharm on September 2, 2024 and sell it today you would earn a total of  510.00  from holding SYN Tech Chem Pharm or generate 5.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

SYN Tech Chem Pharm  vs.  Medigen Vaccine Biologics

 Performance 
       Timeline  
SYN Tech Chem 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in SYN Tech Chem Pharm are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, SYN Tech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Medigen Vaccine Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medigen Vaccine Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

SYN Tech and Medigen Vaccine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SYN Tech and Medigen Vaccine

The main advantage of trading using opposite SYN Tech and Medigen Vaccine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SYN Tech position performs unexpectedly, Medigen Vaccine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Vaccine will offset losses from the drop in Medigen Vaccine's long position.
The idea behind SYN Tech Chem Pharm and Medigen Vaccine Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital